WASHINGTON – Federal health regulators are warning the public that certain cardiac defibrillators recalled by Philips Healthcare may fail to deliver a needed shock in an emergency. Defibrillators are ...
Philips receives FDA premarket approval for its HeartStart OnSite and HeartStart Home defibrillators
Amsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) of the Food and Drug ...
The Philips HeartStart OnSite Defibrillator is designed to be the easiest-to-use, and most reliable defibrillator available. Available without a prescription from ActiveForever.com, the Philips ...
The therapy delivered by the HeartStart FR2+ is the most proven in the industry. More than 40 studies confirm its effectiveness. Philips’ high-current/low energy therapy ensures a potent ...
Philips HeartStart OnSite AEDs help allow anyone with little or no training to treat the most common cause of suspected sudden cardiac arrest (SCA) by delivering a shock quickly and effectively, ...
Amsterdam, the Netherlands and Cambridge, MA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) of ...
Philips recalled its HeartStart MRx Defibrillator due to an equipment defect, according to a Feb. 9 safety notice from the FDA. Here are three things to know. 1. Philips initiated the recall in June ...
Royal Philips, a global leader in health technology, announced that the Center for Devices and Radiological Health (CDRH) of the US Food and Drug Administration (FDA) has granted premarket approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results